Smith Andrew Alasdair bought MDCX
March 30, 2026 · Form 4 insider transaction
Smith Andrew Alasdair bought 50,000 shares of Medicus Pharma Ltd. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
50,000
Price
$0.00
Total value
N/A
InsiderSmith Andrew Alasdair
Role—
CompanyMedicus Pharma Ltd. (MDCX)
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateMarch 30, 2026
Filing dateApril 1, 2026
Shares owned after50,000
OwnershipDirect
10b5-1 planNo
AmendedNo